DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Beigel JH, Voell J, Kumar P. et al.
Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study.
Lancet Infect Dis 2018;
18 (04) 410-418
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.